AEHR — AEHR Test Systems Income Statement
0.000.00%
- $260.80m
- $231.39m
- $66.22m
- 53
- 54
- 13
- 34
Annual income statement for AEHR Test Systems, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 22.3 | 16.6 | 50.8 | 65 | 66.2 |
Cost of Revenue | |||||
Gross Profit | 8.37 | 6.03 | 23.7 | 32.7 | 32.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 25.1 | 18.6 | 41.3 | 51.6 | 56.1 |
Operating Profit | -2.77 | -2 | 9.5 | 13.4 | 10.1 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.77 | -2.2 | 9.54 | 14.6 | 12.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.8 | -2.03 | 9.45 | 14.6 | 33.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2.8 | -2.03 | 9.45 | 14.6 | 33.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.8 | -2.03 | 9.45 | 14.6 | 33.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.116 | -0.147 | 0.28 | 0.498 | 1.12 |